453 related articles for article (PubMed ID: 27563063)
21. Prion-Protein-interacting Amyloid-β Oligomers of High Molecular Weight Are Tightly Correlated with Memory Impairment in Multiple Alzheimer Mouse Models.
Kostylev MA; Kaufman AC; Nygaard HB; Patel P; Haas LT; Gunther EC; Vortmeyer A; Strittmatter SM
J Biol Chem; 2015 Jul; 290(28):17415-38. PubMed ID: 26018073
[TBL] [Abstract][Full Text] [Related]
22. Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.
Crestini A; Santilli F; Martellucci S; Carbone E; Sorice M; Piscopo P; Mattei V
J Alzheimers Dis; 2022; 85(2):503-518. PubMed ID: 34864675
[TBL] [Abstract][Full Text] [Related]
23. Soluble Prion Peptide 107-120 Protects Neuroblastoma SH-SY5Y Cells against Oligomers Associated with Alzheimer's Disease.
Rezvani Boroujeni E; Hosseini SM; Fani G; Cecchi C; Chiti F
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019683
[TBL] [Abstract][Full Text] [Related]
24. Ca(2+)/calmodulin-dependent protein kinase II interacts with group I metabotropic glutamate and facilitates receptor endocytosis and ERK1/2 signaling: role of β-amyloid.
Raka F; Di Sebastiano AR; Kulhawy SC; Ribeiro FM; Godin CM; Caetano FA; Angers S; Ferguson SS
Mol Brain; 2015 Mar; 8():21. PubMed ID: 25885040
[TBL] [Abstract][Full Text] [Related]
25. Cellular prion protein and Alzheimer disease: link to oligomeric amyloid-β and neuronal cell death.
Kudo W; Petersen RB; Lee HG
Prion; 2013; 7(2):114-6. PubMed ID: 23154635
[TBL] [Abstract][Full Text] [Related]
26. Alzheimer's Aβ interacts with cellular prion protein inducing neuronal membrane damage and synaptotoxicity.
Peters C; Espinoza MP; Gallegos S; Opazo C; Aguayo LG
Neurobiol Aging; 2015 Mar; 36(3):1369-77. PubMed ID: 25599875
[TBL] [Abstract][Full Text] [Related]
27. Neuronal pathophysiology featuring PrP
Bertoli A; Sorgato MC
Prion; 2018 Jan; 12(1):28-33. PubMed ID: 29227178
[TBL] [Abstract][Full Text] [Related]
28. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.
Laurén J; Gimbel DA; Nygaard HB; Gilbert JW; Strittmatter SM
Nature; 2009 Feb; 457(7233):1128-32. PubMed ID: 19242475
[TBL] [Abstract][Full Text] [Related]
29. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
[TBL] [Abstract][Full Text] [Related]
30. Disease-associated mutations in the prion protein impair laminin-induced process outgrowth and survival.
Machado CF; Beraldo FH; Santos TG; Bourgeon D; Landemberger MC; Roffé M; Martins VR
J Biol Chem; 2012 Dec; 287(52):43777-88. PubMed ID: 23132868
[TBL] [Abstract][Full Text] [Related]
31. Cellular prion protein participates in amyloid-β transcytosis across the blood-brain barrier.
Pflanzner T; Petsch B; André-Dohmen B; Müller-Schiffmann A; Tschickardt S; Weggen S; Stitz L; Korth C; Pietrzik CU
J Cereb Blood Flow Metab; 2012 Apr; 32(4):628-32. PubMed ID: 22293988
[TBL] [Abstract][Full Text] [Related]
32. The Link of the Prion Protein with Ca
De Mario A; Peggion C; Massimino ML; Norante RP; Zulian A; Bertoli A; Sorgato MC
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546771
[TBL] [Abstract][Full Text] [Related]
33. Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer's disease.
Haas LT; Salazar SV; Kostylev MA; Um JW; Kaufman AC; Strittmatter SM
Brain; 2016 Feb; 139(Pt 2):526-46. PubMed ID: 26667279
[TBL] [Abstract][Full Text] [Related]
34. Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease.
Um JW; Strittmatter SM
Prion; 2013; 7(1):37-41. PubMed ID: 22987042
[TBL] [Abstract][Full Text] [Related]
35. Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid-β oligomers.
Jarosz-Griffiths HH; Corbett NJ; Rowland HA; Fisher K; Jones AC; Baron J; Howell GJ; Cowley SA; Chintawar S; Cader MZ; Kellett KAB; Hooper NM
J Biol Chem; 2019 Apr; 294(17):7085-7097. PubMed ID: 30872401
[TBL] [Abstract][Full Text] [Related]
36. Amyloid-β oligomers interact with NMDA receptors containing GluN2B subunits and metabotropic glutamate receptor 1 in primary cortical neurons: Relevance to the synapse pathology of Alzheimer's disease.
Taniguchi K; Yamamoto F; Amano A; Tamaoka A; Sanjo N; Yokota T; Kametani F; Araki W
Neurosci Res; 2022 Jul; 180():90-98. PubMed ID: 35257837
[TBL] [Abstract][Full Text] [Related]
37. Aptamer-Induced-Dimerization Strategy Attenuates AβO Toxicity through Modulating the Trophic Activity of PrP
Liu S; Li S; Lin J; Li J; Yang H
J Am Chem Soc; 2022 Jun; 144(21):9264-9270. PubMed ID: 35583938
[TBL] [Abstract][Full Text] [Related]
38. Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer's disease.
Ostapchenko VG; Beraldo FH; Guimarães AL; Mishra S; Guzman M; Fan J; Martins VR; Prado VF; Prado MA
J Neurochem; 2013 Nov; 127(3):415-25. PubMed ID: 23651058
[TBL] [Abstract][Full Text] [Related]
39. Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease.
Abd-Elrahman KS; Ferguson SSG
Annu Rev Pharmacol Toxicol; 2022 Jan; 62():235-254. PubMed ID: 34516293
[TBL] [Abstract][Full Text] [Related]
40. Dextran sulfate sodium inhibits amyloid-β oligomer binding to cellular prion protein.
Aimi T; Suzuki K; Hoshino T; Mizushima T
J Neurochem; 2015 Aug; 134(4):611-7. PubMed ID: 25963375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
